CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
Speech Production Treatmentbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02046941
NCT02046941N/ACompleted
CompareCT.gov

Brain Biomarkers of Response to Treatment for Apraxia of Speech

VA Office of Research and Development·interventional·Posted Jan 28, 2014·Updated Aug 28, 2019

In Brief

A clinical study evaluating Speech Production Treatment for Aphasia and Stroke. Completed, enrolled 17 participants across 1 site.

Detailed Summary

The study will use MRI brain imaging to identify brain changes associated in stroke patients after they receive speech-language treatment for their speech difficulties.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAphasia, Stroke
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 28, 2014
Enrollment StartMar 1, 2014
Primary CompletionJan 8, 2018
Study CompletionJun 30, 2018
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 12.4 years ago

Interventions

Speech Production Treatmentbehavioral

This treatment employs a response-contingent hierarchy made up of verbal modeling/repetition, graphic cueing, integral stimulation, and articulatory placement instruction.